Emmessar Biotech & Nutrition Limited

₹21.42As of Sun 8 Nov 2026, 12:00 UTC
BSE:524768Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 0.69%
Div yield —
ROE 5.16%
Pharmaceutical Preparations
Beta (5Y) 0.25
PE TTM 25.48
TSR TTM (30.97%)
Mkt cap ₹107.0M
ROIC 15.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹25
14.89%
(43.39%)
Hold 4|11|2|12|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.20
0.21
0.21
0.22
3.59%
12.35%
13.74%
13.35%
Revenue₹M
9.037
9.216
9.366
9.198
13.37%
12.34%
10.31%
2.60%
Peers (US$1.196M)
Cap (US$)
PE
1.397M
21.01x
1.314M
75.47x
Capital
TTM
5Y
10Y
Leveragex
3.448
0.788
0.619
EBIT/Intx
1.023
0.213
0.208
Own earn%
113.22
(79.06)
(78.73)
Sh yield%
19.19
24.24
22.41
Owners
Insiders/Inst%
10.23
48.11
Short interest%
3.51
SBC / revenue%
1.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
31–41
$1 testx
−0.1
Incr. ROIC%
8